Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis

Dupilumab is a monoclonal antibody against interleukin 4 receptor alpha and has proven to be clinically effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). However, a certain...

Source: Journal of Otolaryngology - Head and Neck Surgery - November 25, 2023 Category: ENT & OMF Authors: Faris F. Brkic, David T. Liu, Iris R ücklinger, Nicholas James Campion, Tina Josefin Bartosik, Erich Vyskocil, Victoria Stanek, Aldine Tu, Katharina Gangl and Sven Schneider Tags: Original research article Source Type: research